A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

NCT07099898 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Lung

Interventions

BIOLOGICAL: Ris-Rez
DRUG: Topotecan

Sponsor

GlaxoSmithKline